https://www.pharmamanufacturing.com/industry-news/news/55369507/recipharm-reduces-scope-1-and-2-emissions-achieves-renewable-power-goalPharma Manufacturingen2026-04-08T16:18:06.000ZRecipharm reduces Scope 1 and 2 emissions, achieves renewable power goalhttps://www.pharmamanufacturing.com/industry-news/news/55369504/israels-scinai-separates-cdmo-business-from-rd-operationsPharma Manufacturingen2026-04-08T16:10:15.000ZIsrael’s Scinai separates CDMO business from R&D operationshttps://www.pharmamanufacturing.com/industry-news/news/55369231/akari-therapeutics-wuxi-xdc-team-to-advance-rna-splicing-adc-payloadPharma Manufacturingen2026-04-07T16:12:44.000ZAkari Therapeutics, WuXi XDC team to advance RNA splicing ADC payloadhttps://www.pharmamanufacturing.com/industry-news/news/55369225/sk-bioscience-maintains-esg-a-rating-for-third-consecutive-yearPharma Manufacturingen2026-04-07T16:12:03.000ZSK bioscience maintains ESG ‘A’ rating for third consecutive year